Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-18 Sale |
2021-11-19 7:39 pm |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
15,000 | $20.02 | $300,300 | 335,000 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-06 8:34 pm |
2025-06-05 2034-06-05 |
Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director |
1,333 | $0 | 1,333 (Direct) |
View |
| 2024-04-05 Equity Swap |
2024-04-08 4:14 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
121,647 | $0 | 0 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 6:01 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J CHIEF EXECUTIVE OFFICER |
13,032 | $1.34 | 211,822 (Direct) |
View |
| 2023-11-06 Option Award |
2023-11-08 6:09 pm |
N/A 2025-04-21 |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
2,449,846 | $0 | 2,449,846 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:18 pm |
2023-06-18 2033-05-18 |
Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 5:09 pm |
N/A 2033-03-01 |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
1,008,800 | $0 | 1,106,454 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:51 pm |
2023-06-07 2032-06-07 |
Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-04 4:06 pm |
N/A 2032-03-02 |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 5:09 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
4,667 | $8.14 | 242,500 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 5:09 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
12,987 | $7.7 | 242,500 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 5:09 pm |
N/A 2027-01-19 |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
17,654 | $0 | 242,500 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-19 7:39 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
15,000 | $7.54 | 335,000 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-19 7:39 pm |
N/A 2025-04-21 |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
15,000 | $0 | 335,000 (Direct) |
View |
Ownership |
2021-08-16 7:52 pm |
N/A N/A |
Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director |
0 | $0 | 35,129 (Direct) |
View |
| 2021-03-17 Option Award |
2021-03-18 8:23 pm |
N/A 2031-03-16 |
NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer |
450,000 | $0 | 450,000 (Direct) |
View |